Publication |
The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling. Chithelen J, Franke H, Länder N, Grafen A, Schneider-Schaulies J. Front Physiol. 2022 Mar 17;13:856143. doi: 10.3389/fphys.2022.856143. eCollection 2022.
|
The Manifold Roles of Sphingolipids in Viral Infections. Avota E, Bodem J, Chithelen J, Mandasari P, Beyersdorf N, Schneider-Schaulies J. Front Physiol. 2021 Sep 29;12:715527. doi: 10.3389/fphys.2021.715527. eCollection 2021.
|
Use of Acid Ceramidase and Sphingosine Kinase Inhibitors as Antiviral Compounds Against Measles Virus Infection of Lymphocytes in vitro. Grafen A, Schumacher F, Chithelen J, Kleuser B, Beyersdorf N, Schneider-Schaulies J. Front Cell Dev Biol. 2019 Oct 1;7:218. doi: 10.3389/fcell.2019.00218. eCollection 2019.
|
|
|